Emergency department thrombolysis critical pathway reduces door‐to‐drug times in acute myocardial infarction
Why the study?
Does an emergency department thrombolysis critical pathway reduce door-to-drug times in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction (AMI) presenting to the Emergency Department
Comparison
Establishment of an AMI thrombolysis critical… vs Prior to establishment of the AMI critical pathway
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
May support ED pathways to shorten AMI thrombolysis times; leaves open confirmation via randomized trials before practice change.
Structured PICO
Does an emergency department thrombolysis critical pathway reduce door-to-drug times in patients with acute myocardial infarction?
P
Population
Patients with acute myocardial infarction (AMI) presenting to the Emergency Department
I
Intervention
Establishment of an AMI thrombolysis critical pathway in the Emergency Department
C
Comparator
Prior to establishment of the AMI critical pathway (historical control)
O
Outcome
Door-to-drug time (time between patient arrival and start of thrombolysis)
Implementation of an emergency department critical pathway significantly reduces door-to-drug times for thrombolysis in acute myocardial infarction and helps narrow the gender gap in treatment delays.
Cite This Study
Cannon et al. (1999) studied this question.